Skip to evidence report

FIB.adventitial.complement_angiocrine: Studies — page 7

How association tiers are defined — cell–trait and gene–trait

SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.

Cell–trait tiers

Cell–trait links
Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
Required for Specific or Relevant
The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
Specific (Tier 1)
Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
Relevant (Tier 2)
Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
Interpretation and report values
CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
Meta traits and individual traits
Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.

Gene–trait priorities (variant–tCRE–gene evidence)

Variant–tCRE–gene links
Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
Required genetic support
The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
Required cellular support
The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
High priority
Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
Medium priority
Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
Same-record evidence and aggregation
Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
Limits of interpretation
A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.

State · 5,164 full-atlas cells · all tissues.

Marker genes and cell annotation · Open this population in Cell Browser →

ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.

Rows 6,001–7,000 of 12,313; ranked by score descending. Equal values use name/identifier order.

Studies ranked for FIB.adventitial.complement_angiocrine
#Trait / studyIndividual trait IDMean IC score
6001IL1RL1 levelsGCST904695740.13
6002SIGLEC7 levelsGCST904706350.13
6003Vanillactate levelsGCST901999780.13
6004CD58 levelsGCST904686380.13
6005PZP levelsGCST904703990.13
6006COX5B/METAP1D ratioGCST903142010.13
6007OLR1/PLAUR ratioGCST903155840.13
6008Estimated glomerular filtration rate, serum creatinine + cystain C | Other measurementUKBB000002110.13
6009Phospholipids to total lipids in large VLDL percentage (UKB data field 23589)GCST902696860.13
6010ICD10 N87: Dysplasia of cervix uteriGCST904542180.13
6011IL1R2 levelsGCST904695720.13
6012Volume of left lateral nucleusGCST904748890.13
60131-palmitoyl-2-stearoyl-gpc (16:0/18:0) levelsGCST902000410.13
6014Cancer of kidney and renal pelvis (PheCode 189.1)GCST904755950.13
6015RBM17 levelsGCST904704340.13
6016PDGFB/SNAP29 ratioGCST903156270.13
6017IDP T1 FAST ROIs R thalamusGCST900025480.13
6018Volume of right paralaminar nucleusGCST904749280.13
6019Asparagine levelsGCST902437580.13
6020Nontoxic uninodular goiter (PheCode 241.1)GCST904756400.13
6021Carcinoma in situ of breast, intraductal (controls excluding all cancers)FING000002400.13
6022TNFAIP8L2 levelsGCST904708970.13
6023BCR levelsGCST904684360.13
6024LDLRAP1 levelsGCST904697490.13
6025DTI autoptx MD ilf r tractGCST903852350.12
6026REG3A levelsGCST904704490.12
6027IDP dMRI TBSS FA Posterior thalamic radiation RGCST900039050.12
6028ACAA1 levelsGCST904681930.12
6029LAIR2 levelsGCST904697290.12
6030Corns and callosities (PheCode 700)GCST904761960.12
6031Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T59ECGU0000590.12
6032YES1 levelsGCST904710880.12
6033PLAUR/TREM2 ratioGCST903156760.12
6034Concentration of large HDL particlesGCST900928510.12
6035aparc-a2009s rh volume S-intrapariet+P-transGCST900030540.12
6036EDAR levelsGCST904690680.12
6037FCRLB levelsGCST904692100.12
6038GIMAP7 levelsGCST904693450.12
6039ATOX1/SPARC ratioGCST903133750.12
6040IFIH1 levelsGCST904236890.12
6041T1 FreeSurfer a2009s lh G precentral volumeGCST903848440.12
6042KLK1 levelsGCST904697020.12
6043CD99 levelsGCST904686580.12
6044Treatment/medication code - amlodipine | MedicationsUKBB000008400.12
6045Benign paroxysmal vertigoFING000002100.12
6046ARL13B levelsGCST904683630.12
6047triglyceride (maximum, inv-norm transformed)GCST904764310.12
6048REST UKBBICA NODEamps25 0014GCST903854970.12
6049IDP dMRI TBSS MD Anterior limb of internal capsule LGCST900040440.12
6050CCL16 levelsGCST904685680.12
6051IDS/SMPDL3A ratioGCST903151260.12
6052DAB2 levelsGCST904689420.12
60531-palmitoyl-2-linoleoyl-GPC (16:0/18:2) metabolite levelGCST906164050.12
6054GOPC levelsGCST904693770.12
6055S100G levelsGCST904705190.12
6056DTI TBSS L3 Superior corona radiata LGCST903845490.12
6057SpondylosisFING000013270.12
6058PCDH9 levelsGCST904701720.12
6059CASP3 levelsGCST904685450.12
6060Phospholipids to total lipids in very large VLDL percentage (UKB data field 23584)GCST902696810.12
6061DNMBP levelsGCST904690230.12
6062SMAD1 levelsGCST904706750.12
6063CCL7 levelsGCST904685850.12
6064REST UKBBICA NET100 1212GCST903870660.12
6065T1 CAT volume R InsularCortexGCST903840030.12
6066Operation code - squint correction | OperationsUKBB000005660.12
6067Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T93ECGU0000930.12
6068Comorbidity of gastric and duodenal ulcersGCST902709290.12
6069IDP dMRI ProbtrackX FA ptr lGCST900039440.12
6070LTBR levelsGCST904698160.12
6071IRAK1/SPRY2 ratioGCST903151960.12
6072DTI autoptx L2 unc r tractGCST903851920.12
6073Heart rate variability (standard deviation of normal-to-normal intervals)GCST902812650.12
6074Omega-3 fatty acid levelsGCST905024230.12
6075COLEC12/TNFRSF1A ratioGCST903141870.12
6076HydroceleFING000006270.12
6077LIFR levelsGCST904697690.12
6078Calculus of kidney (PheCode 594.1)GCST904761450.12
6079DDR1 levelsGCST904689700.12
6080Mood swings | Mental healthUKBB000004820.12
6081CD46 levelsGCST904686340.12
6082SERPINA11 levelsGCST904705800.12
6083wg rh intensity-contrast middletemporalGCST900038410.12
6084HHEX levelsGCST904694510.12
6085Total lipid levels in large HDLGCST900928500.12
6086TWF2 levelsGCST904709870.12
6087Left-hemisphere visual network to right-hemisphere default mode network white-matter structural connectivityGCST903026610.12
6088triglyceride (mean, inv-norm transformed)GCST904764350.12
6089TRIM25 levelsGCST904709660.12
6090CTSF levelsGCST904689120.12
6091CST3 levelsGCST904688940.12
6092BLVRB/HMBS ratioGCST903135260.12
6093Type 2 diabetes, wide definitionFING000013830.12
6094IDP T1 SIENAX grey normalised volumeGCST900024300.12
6095Estimated glomerular filtration rate (creatinine)GCST904284470.12
6096TNFRSF11A levelsGCST902776440.12
6097SHBG levelsGCST904706220.12
6098AmygNuclei lh volume Accessory-Basal-nucleusGCST900026500.12
6099CD300LG levelsGCST904686230.12
6100Chronic Kidney Disease, Stage III (PheCode 585.33)GCST904761280.12
6101IDP T1 FAST ROIs L thalamusGCST900025470.12
6102Abscess of anal and rectal regionsFING000000050.12
6103SYT1 levelsGCST904707940.11
6104Phlebitis and thrombophlebitis of lower extremities (PheCode 451.2)GCST900440250.11
6105Father's age | Family historyUKBB000002400.11
6106Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T485ECGA0004850.11
6107Pollen allergyFING000011760.11
6108FKBP1B/PRDX5 ratioGCST903148330.11
6109GFER/MAVS ratioGCST903149190.11
6110Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T96ECGU0000960.11
6111BCR/PLXNA4 ratioGCST903134970.11
6112Methods of admission to hospital (recoded) - Elective admission: Waiting List | Summary AdministrationUKBB000004630.11
6113Cerebral ischemia (PheCode 433.3)GCST904759880.11
6114triglyceride (minimum, inv-norm transformed)GCST904764390.11
6115IL1RN levelsGCST900120040.11
6116MGLL/PTPN6 ratioGCST903154400.11
6117wg rh intensity-contrast fusiformGCST900038330.11
6118TNFRSF14/TNFRSF1A ratioGCST903159350.11
6119APRT/CD63 ratioGCST903133340.11
6120AMBP/HAVCR1 ratioGCST903132540.11
6121Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T72ECGU0000720.11
6122PDGF-BB levelsGCST904284300.11
6123MANF/PRDX5 ratioGCST903153650.11
6124NQO2 levelsGCST902426790.11
6125CKAP4/PGF ratioGCST903140750.11
6126Left ventricular mass (indexed to body surface area)GCST904352600.11
6127Blood cell traits latent factor 9 (white cell)GCST905592510.11
6128GALNT10 levelsGCST904692950.11
6129Operation code - spinal laminectomy | OperationsUKBB000005640.11
61301-stearoyl-2-arachidonoyl-GPC (18:0/20:4) metabolite levelGCST906156700.11
6131Qualifications - Other professional qualifications eg: nursing, teaching | EducationUKBB000007320.11
6132CACYBP levelsGCST904685240.11
6133Placental weight (paternal genotype, adjusted for sex)GCST902751990.11
6134Grapefruit likingGCST900947740.11
6135Medication use (immunosuppressants)GCST900187710.11
6136Neuroendocrine tumor and carcinoma of pancreas, excluding all cancers (controls excluding all cancers)FING000008640.11
6137IDP SWI T2star left putamenGCST900038670.11
6138MANF/PDGFB ratioGCST903153600.11
6139Monounsaturated fatty acids to total fatty acids percentageGCST905023880.11
6140Urinary calculus (PheCode 594)GCST904761430.11
6141PODXL2 levelsGCST904702790.11
6142Subarachnoid hemorrhageGCST900187030.11
6143Chronic bronchitis | respiratoryUKBB000001360.11
6144ANPEP/DPP4 ratioGCST903132730.11
6145DPP6 levelsGCST904690340.11
6146MUC16 levelsGCST904699640.11
6147WASHC3 levelsGCST904710690.11
6148Idiopathic pulmonary fibrosisFING000006590.11
6149FAM172A levelsGCST904691840.11
6150Atherosclerosis, excluding cerebral and coronary sclerosisFING000001230.11
6151TARBP2 levelsGCST904708050.11
6152CX3CL1/RGMB ratioGCST903143270.11
6153DSG2 levelsGCST904278250.11
6154Vitamin and mineral supplements - None of the above | MedicationUKBB000009010.11
6155Congenital malformations of heart and great arteriesFING000003360.11
6156COMP/DPP4 ratioGCST903141880.11
6157Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T495ECGU0004950.11
6158BCAN/KLK6 ratioGCST903134790.11
6159high density lipoprotein cholesterol (HDLC, minimm, inv-norm transformed)GCST904753560.11
6160LSP1/NADK ratioGCST903153310.11
6161IL34 levelsGCST904695930.11
6162LDLR levelsGCST901793460.11
6163NAGK levelsGCST904699950.11
6164IDP dMRI ProbtrackX L1 ifo lGCST900042580.11
6165TBCA levelsGCST904708120.11
6166aseg lh intensity Accumbens-areaGCST900037740.11
6167TXLNA levelsGCST904709890.11
6168LAT2/YES1 ratioGCST903152820.11
6169Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T233ECGU0002330.11
6170DTI autoptx FA ifo l tractGCST903851240.11
6171Total Sphingomyelin levelsGCST900258420.11
6172SNAP23/TBL1X ratioGCST903158560.11
6173BA-exvivo rh area BA2GCST900032220.11
6174Left-hemisphere limbic network to right-hemisphere salience/ventral attention network white-matter structural connectivityGCST903027320.11
6175NID1/SORT1 ratioGCST903155420.10
6176Fasting blood glucoseGCST0051860.10
6177EIF4G1/FOXO1 ratioGCST903146340.10
6178Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T105ECGU0001050.10
6179DSC2/SPINT1 ratioGCST903145570.10
6180aseg lh volume HippocampusGCST900026240.10
6181NUCB2 levelsGCST904701010.10
6182Recent feelings or nervousness or anxiety | AnxietyUKBB000007410.10
6183DTI TBSS L1 Posterior thalamic radiation LGCST903844570.10
6184Blood cell traits latent factor 1 (white cell)GCST905592430.10
6185T1 FreeSurfer aseg Right-PallidumGCST903841640.10
6186Medication use (drugs affecting bone structure and mineralization)GCST900187730.10
6187Interpolated Year when non-cancer illness first diagnosed | Medical conditionsUKBB000003710.10
6188TPPP3 levelsGCST904709480.10
6189Late-onset myasthenia gravisGCST900934660.10
6190MANF/SNX9 ratioGCST903153680.10
6191Right ventricular ejection fractionGCST902681170.10
6192VSTM1 levelsGCST904710550.10
6193PIKFYVE levelsGCST904702350.10
6194Creatinine levelsGCST904972370.10
6195Depression | Mental distressUKBB000001650.10
6196Bioavailable testosterone levelsGCST900121020.10
6197EXTL1 levelsGCST904691610.10
6198CCL14/CST3 ratioGCST903136790.10
6199Phosphatidylcholine diacyl C38:3 levelsGCST902400450.10
6200ConstipationFING000003480.10
6201Triacylglycerol_45:4_[M+NH4]1+ levelsGCST900603330.10
6202NBL1 levelsGCST904700010.10
6203IDP dMRI TBSS MD Genu of corpus callosumGCST900040290.10
6204DTI autoptx L2 fmi tractGCST903851770.10
6205T1 FreeSurfer pial rh posteriorcingulate areaGCST903858440.10
6206rfMRI connectivity (ICA25 edge 103)GCST900047460.10
6207BCR/ITGB1BP2 ratioGCST903134940.10
6208PRKAB1 levelsGCST904703240.10
6209CCDC80 levelsGCST904685620.10
6210ENO2/PLXNA4 ratioGCST903146650.10
6211Weight | Impedance measuresUKBB000009100.10
6212Allergic rhinitisFING000000710.10
6213Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T45ECGA0000450.10
6214DTI TBSS FA Anterior corona radiata LGCST903844030.10
6215AXIN1/MAVS ratioGCST903134140.10
6216Seen doctor (GP) for nerves, anxiety, tension or depression | Mental healthUKBB000007650.10
6217Heart failure with reduced EF [Systolic or combined heart failure] (PheCode 428.3)GCST904759830.10
6218CALCOCO1/MAP3K5 ratioGCST903136050.10
6219Hemoglobin A1c (HbA1c, minimum, inv-norm transformed)GCST904750970.10
6220Principal component-derived dietary pattern 26GCST901330310.10
6221T1 FreeSurfer DK rh MeanThickness thicknessGCST903857570.10
6222Triacylglycerol_53:2_[M+NH4]1+ levelsGCST900605310.10
6223GZMA/TNFRSF8 ratioGCST903150140.10
6224Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T429ECGU0004290.10
6225Nonischemic cardiomyopathyFING000008830.10
6226CDKN1A/NCK2 ratioGCST903139730.10
6227DAB2/TBL1X ratioGCST903143680.10
6228aparc-a2009s rh volume G-front-inf-TriangulGCST900030120.10
6229Lymphocyte countGCST900187420.10
6230Docosahexaenoic acid levelsGCST905022580.10
6231SERPINA4 levelsGCST904705840.10
6232IDP dMRI TBSS FA Superior fronto-occipital fasciculus RGCST900039190.10
6233CABP2 levelsGCST904685190.10
6234DTI TBSS L3 Anterior corona radiata LGCST903845470.10
6235LONP1 levelsGCST904697850.10
6236IDP dMRI TBSS ICVF Cingulum cingulate gyrus RGCST900043610.10
6237GHR levelsGCST904693420.10
6238Hip circumference | Body size measuresUKBB000003280.10
6239CALCOCO2 levelsGCST904685310.10
6240NBN levelsGCST904700020.10
6241ADAM22 levelsGCST904682180.10
6242Physical activity (Total log acceleration 6am-8am)GCST900614120.10
6243Other circulatory problemGCST904752170.10
6244Subarachnoid haemorrhageFING000013390.10
6245Straight vs curly hairGCST0060940.10
6246Other extrapyramidal and movement disorders in other diseasesFING000010470.10
6247IDP T1 FAST ROIs L pallidumGCST900025530.10
6248Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T469ECGA0004690.10
6249wg rh intensity-contrast cuneusGCST900038310.10
6250GZMA/GZMH ratioGCST903150080.10
6251CNDP1/EGFR ratioGCST903141460.10
6252ERBB3 levelsGCST904691400.10
6253CCL18/RARRES2 ratioGCST903136900.10
6254XCL1 levelsGCST904710810.10
6255NCF2 levelsGCST904700060.10
6256Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T106ECGU0001060.10
6257GZMA/IL12A_IL12B ratioGCST903150090.10
6258Sources of admission to hospital (recoded) - Usual Place of residence | Summary AdministrationUKBB000007860.09
6259aparc-a2009s lh volume S-circular-insula-supGCST900029730.09
6260Asthma (adult onset)GCST0077990.09
6261RPE levelsGCST904704950.09
6262Phosphatidylcholine-O_36:2_[M+H]1+/Phosphatidylcholine-P_36:1_[M+H]1+/Phosphatidylethanolamine-P_39:1_[M+H]1+ levelsGCST900603260.09
6263estimated glomerular filtration rate (eGFR, minimum, inv-norm transformed)GCST904752850.09
6264ABL1 levelsGCST904681900.09
6265LSIL lesion of the cervix uteriFING000007320.09
6266SIRPA levelsGCST904706390.09
6267Amyotrophic lateral sclerosisGCST900271640.09
6268IRAG2 levelsGCST904696260.09
6269Back pain | symptomsUKBB000000840.09
6270Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T58ECGA0000580.09
6271Heart rate variability (corrected root mean square of successive differences)GCST902812640.09
6272mean corpuscular hemoglobin concentration (MCHC, minimum, inv-norm transformed)GCST904754600.09
6273T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 13)GCST903205760.09
6274Cerebrospinal fluid unidentified metabolite levels (HILIC Metabolomics ID: 8.07_212.10)GCST902918050.09
6275Beetroot likingGCST900947020.09
6276CRADD/FADD ratioGCST903142370.09
6277RAD23B levelsGCST904704180.09
6278Lysophosphatidylcholine (20:3) [sn1] levelsGCST900241690.09
6279IDP dMRI ProbtrackX ISOVF ifo rGCST900045380.09
6280aparc-a2009s lh area S-precentral-sup-partGCST900033650.09
6281METAP1D/PLXNA4 ratioGCST903154270.09
6282Colonic or urogenital fistulaFING000003150.09
6283CD248 levelsGCST904686120.09
6284AMOT levelsGCST904682950.09
6285GATD3 levelsGCST904693090.09
6286COX5B/GFER ratioGCST903142000.09
6287red blood cell count (RBC, mean, inv-norm transformed)GCST904763490.09
6288Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T441ECGU0004410.09
6289PLTP levelsGCST904702620.09
6290TIMM10 levelsGCST904708670.09
6291DNPH1/NSFL1C ratioGCST903145260.09
6292X-12411 levelsGCST902004920.09
6293AXL/MSR1 ratioGCST903134220.09
6294ANXA3 levelsGCST904683180.09
6295SPTLC1 levelsGCST904271300.09
6296ELN levelsGCST904691030.09
6297RGCC levelsGCST904704610.09
6298CD164/PARK7 ratioGCST903137430.09
6299Divergent concomitant strabismusFING000004700.09
63003-methyl-2-oxovalerate levelsGCST902434850.09
6301Congenital iodine-deficiency syndrome/hypothyroidismFING000003280.09
6302IDP dMRI ProbtrackX ICVF cst rGCST900043840.09
6303Weight | Body size measuresUKBB000009090.09
6304Immature fraction of reticulocytesGCST900259710.09
6305VAMP8 levelsGCST904710250.09
6306BCL2L1 levelsGCST904684320.09
6307ADAM12 levelsGCST904682160.09
6308IDP T1 FIRST right putamen volumeGCST900024410.09
6309GABBR2 levelsGCST902412300.09
6310LGMN levelsGCST904697660.09
6311T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 86)GCST903206490.09
6312CTSL levelsGCST904689140.09
6313AsthmaGCST0100420.09
6314GPD1 levelsGCST904693880.09
6315Average diameter for HDL particlesGCST900928280.09
6316ERBB4 levelsGCST904691410.09
6317Hip circumference (UKB data field 49)GCST904681700.09
6318Chronic airway obstruction (PheCode 496)GCST904760270.09
6319Right bundle branch block (PheCode 426.31)GCST904759570.09
63201-(1-enyl-palmitoyl)-GPC (p-16:0) levelsGCST901998990.09
6321Attention deficit hyperactivity disorderGCST0053620.09
6322AcneFING000000100.09
6323Carotid artery plaque burdenGCST905030760.09
6324ThalamNuclei rh volume MGNGCST900027370.09
6325YOD1 levelsGCST904710900.09
6326DNAJA2/SCAMP3 ratioGCST903145070.09
6327Frailty (Factor 5 - Poorer Cognition)GCST906240510.09
6328Myasthenia gravisGCST904321560.09
6329NUDT5 levelsGCST904701070.09
6330T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 73)GCST903206360.09
6331Peripheral vascular diseaseGCST904752190.09
6332JPT2 levelsGCST904696630.09
6333Right-hemisphere salience/ventral attention network to right-hemisphere default mode network white-matter structural connectivityGCST903028160.09
6334PSRC1/SMAD1 ratioGCST903157410.09
6335Wheeze or whistling in the chest in last year (UKB data field 2316)GCST900436140.09
6336TNFSF12 levelsGCST904709190.09
6337IDP dMRI TBSS L1 Anterior corona radiata RGCST900040970.09
6338AIFM1/PLXNA4 ratioGCST903132200.09
6339Pulmonary embolism and infarction, acute (PheCode 415.11)GCST904759460.09
6340NADK/S100A11 ratioGCST903155130.09
6341CDH17/GALNT3 ratioGCST903139400.09
6342PHYKPL levelsGCST904702280.09
6343PTH levelsGCST904703720.09
6344Job involves mainly walking or standing | EmploymentUKBB000003840.09
6345PEAR1/PECAM1 ratioGCST903156410.09
6346CD84 levelsGCST904686530.09
6347ANPEP levelsGCST904683130.09
6348CUZD1 levelsGCST904689190.09
6349Diseases of esophagus (PheCode 530)GCST904760450.09
6350NFKBIE levelsGCST904700390.09
6351LUZP2 levelsGCST904698190.09
6352Percentage of monosialylation of core-fucosylated monogalactosylated structures without bisecting GlcNAc (GP41)GCST906684850.09
6353F3 levelsGCST904691700.09
6354Severe autoimmune type 2 diabetesGCST900264120.09
6355Cerebrospinal fluid 3-hydroxy-2-ethylpropionate levelsGCST903179640.08
6356Follicle stimulating hormone levelsGCST904834760.08
6357Cholesteryl ester levels in HDLGCST900928230.08
6358IFNGR1/IL10RB ratioGCST903151270.08
6359AXIN1 levelsGCST904684050.08
6360ADAMTS15/SULT2A1 ratioGCST903131710.08
6361FEN1 levelsGCST904692130.08
6362Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor - Asthma | Medical conditionsUKBB000000980.08
6363rfMRI amplitudes (ICA25 node 14)GCST900045810.08
63641-(1-enyl-palmitoyl)-2-palmitoyl-GPC (P-16:0/16:0) levelsGCST902000830.08
6365NID2 levelsGCST904700480.08
6366Concentration of medium HDL particles (UKB data field 23565)GCST902696620.08
6367GNE levelsGCST904693700.08
6368CRKL/SERPINB1 ratioGCST903142720.08
6369FOLR3/KLK8 ratioGCST903148680.08
6370SERPINB6 levelsGCST904705910.08
6371DTI TBSS MD Retrolenticular part of internal capsule RGCST903845920.08
6372SEPTIN8 levelsGCST904705780.08
6373wg lh intensity-contrast lingualGCST900038040.08
6374IDP dMRI TBSS ISOVF Anterior corona radiata RGCST900044990.08
6375TG levelsGCST904708510.08
6376DSG2 levelsGCST904237660.08
6377PPP1R12A/SKAP2 ratioGCST903157100.08
6378Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T67ECGU0000670.08
6379SCARA5/TGFBI ratioGCST903158090.08
6380IgA nephropathy (IgA glomerulonephritis)FING000006600.08
6381T1 CAT volume R RightAccumbensGCST903841090.08
6382T1 FreeSurfer BA rh BA2 exvivo volumeGCST903855760.08
6383Bell pepper likingGCST900947030.08
6384Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T485ECGU0004850.08
6385Red blood cell countGCST900023640.08
6386ITGB1BP2/TIA1 ratioGCST903152220.08
6387CDC26 levelsGCST904686630.08
6388Severity of induration at injection site at the injection site after COVID-19 booster vaccinationGCST904544090.08
6389DTI TBSS MD Superior longitudinal fasciculus LGCST903846130.08
6390Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T60ECGU0000600.08
6391CystitisFING000003760.08
6392Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T487ECGA0004870.08
6393IDP dMRI TBSS L1 Anterior limb of internal capsule RGCST900040910.08
6394OGN levelsGCST904701190.08
6395CCN4 levelsGCST904685900.08
6396EREG/MPIG6B ratioGCST903147040.08
6397CXCL10/CXCL11 ratioGCST903143300.08
6398ACOT13 levelsGCST904682000.08
6399VGF levelsGCST904710380.08
6400CD27/ICAM3 ratioGCST903137730.08
6401CA2/CA3 ratioGCST903135760.08
6402Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T489ECGA0004890.08
6403Total protein levelsGCST904681050.08
6404IQGAP2/STX4 ratioGCST903151900.08
6405F-cooking vegetables liking (derived food-liking factor)GCST900947430.08
6406Myasthenia gravisGCST900930610.08
6407Principal component-derived dietary pattern 31GCST901330360.08
6408AmygNuclei rh volume Accessory-Basal-nucleusGCST900026600.08
6409PMVK/RHOC ratioGCST903156970.08
6410Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T464ECGA0004640.08
6411SIRPB1 levelsGCST904706400.08
6412MAP2 levelsGCST904698530.08
6413Volume of right paralaminar nucleusGCST904750480.08
6414Docosahexaenoic acid levelsGCST904972560.08
6415Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T90ECGU0000900.08
6416MANSC1 levelsGCST904698470.08
6417SNCA levelsGCST904706940.08
6418DTI TBSS L2 Posterior thalamic radiation LGCST903845050.08
6419Phospholipids to Total Lipids in Very Small VLDL percentageGCST905008560.08
6420Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T234ECGU0002340.08
6421PPIB levelsGCST904702910.08
6422ATRN levelsGCST904684000.08
6423DDX58 levelsGCST904689770.08
6424GCG levelsGCST904693160.08
6425NFU1 levelsGCST904700400.08
6426Valine levelsGCST905001760.08
6427Diacylglycerol_36:5_[M+H-H2O]1+ levelsGCST900601870.08
6428Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T425ECGU0004250.08
6429VASP levelsGCST904710280.08
6430T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 86)GCST903209050.08
6431Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T482ECGA0004820.08
6432IDP dMRI TBSS ICVF Middle cerebellar peduncleGCST900043270.08
6433Omega-3 fatty acids to Omega-6 fatty acids ratioGCST905020750.08
6434Malignant neoplasm of bladder (PheCode 189.21)GCST904755990.08
6435Left-hemisphere dorsal attention network to left-hemisphere salience/ventral attention network white-matter structural connectivityGCST903026900.08
6436MGMT levelsGCST904699020.08
6437Prescriptions - opioid analgesic|selective serotonin re-uptake inhibitor|norepinephrine re-uptake inhibitorUKBB000006940.08
6438Prescriptions - tramadol | opioid analgesic,selective serotonin re-uptake inhibitor,norepinephrine re-uptake inhibitorUKBB000007060.08
6439SERPINB1 levelsGCST904705890.08
6440ERP44/SUMF2 ratioGCST903147100.08
6441PPP2R5A levelsGCST904703060.08
6442X-13671 levelsGCST902438290.08
6443LAT2/MANF ratioGCST903152770.08
6444Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)FING000007560.08
6445BTD levelsGCST904684770.08
6446PPP1R12A levelsGCST904703000.08
6447Neutrophil countGCST900023980.08
6448ECHDC3 levelsGCST904690620.08
6449INPP1 levelsGCST904696160.08
6450APOM/ERBB3 ratioGCST903133140.08
6451FHIT/MAX ratioGCST903148180.08
6452Minimum carotid IMT (intima-medial thickness) at 210 degrees | Carotid ultrasoundUKBB000004770.08
6453GRAP2/SNX9 ratioGCST903149880.07
6454BPIFB1 levelsGCST904684620.07
6455MICB_MICA/TEK ratioGCST903154460.07
6456IDP dMRI TBSS FA Sagittal stratum RGCST900039070.07
6457Zoster infectionGCST900187210.07
6458aparc-a2009s lh volume G-pariet-inf-SupramarGCST900029500.07
6459Wegener granulomatosisFING000014460.07
6460Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T101ECGU0001010.07
6461White blood cell countGCST900023750.07
6462IDP dMRI ProbtrackX L1 cgc rGCST900042510.07
6463CXCL8 levelsGCST904689340.07
6464Total lipids in very small VLDLGCST905008100.07
6465ITGA5/LILRA2 ratioGCST903152040.07
6466CirrhosisGCST900186060.07
6467HippSubfield lh volume subiculum-bodyGCST900026690.07
6468MECR levelsGCST904698790.07
6469CASP8/SEPTIN9 ratioGCST903136580.07
6470Chronic pancreatitisGCST900186010.07
6471PAK4 levelsGCST904701500.07
6472Free cholesterol levels in large HDLGCST900928480.07
6473PDGFA/SNAP23 ratioGCST903156190.07
6474TAX1BP3 levelsGCST902429760.07
6475BMI (weighted GWA)GCST902672690.07
6476CCL20 levelsGCST900120770.07
6477Tea intake (UKB data field 1488)GCST901329830.07
6478PRKRA levelsGCST904703310.07
6479aparc-Desikan lh area superiorparietalGCST900031010.07
6480RNF5 levelsGCST904704880.07
6481Cholesterol in medium HDL (UKB data field 23568)GCST902696650.07
6482Free Cholesterol to Total Lipids in Very Small VLDL percentageGCST905007980.07
6483ITGB1BP2/LAT2 ratioGCST903152120.07
6484Nephritis and nephropathy without mention of glomerulonephritis (PheCode 580.3)GCST904761150.07
6485IST1 levelsGCST904696320.07
6486FGF19/SCG2 ratioGCST903148090.07
6487ABL1/CC2D1A ratioGCST903131480.07
6488F2R levelsGCST900120100.07
6489CPB1 levelsGCST902405970.07
6490CD69/F2R ratioGCST903138770.07
6491MEGF9/MET ratioGCST903154180.07
6492IDP dMRI ProbtrackX ICVF atr rGCST900043780.07
6493IDP T1 FAST ROIs R cerebellum XGCST900025890.07
6494wg lh intensity-contrast lateralorbitofrontalGCST900038030.07
6495Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T490ECGU0004900.07
6496IDP T1 FIRST left hippocampus volumeGCST900024440.07
6497Phospholipids to total lipids ratio in medium HDLGCST900929010.07
6498S100A13 levelsGCST904705140.07
6499SNCA levelsGCST902402580.07
6500DTI autoptx L2 ilf l tractGCST903851800.07
6501MAX/STK24 ratioGCST903154040.07
6502IDP T1 FAST ROIs L cerebellum VIIIbGCST900025810.07
6503Free cholesterol to total lipids in large VLDL percentage (UKB data field 23592)GCST902696890.07
6504EREG/F2R ratioGCST903147000.07
6505aparc-Desikan rh area parstriangularisGCST900031260.07
6506X-13435 levelsGCST902438110.07
6507IDP dMRI TBSS L1 Anterior limb of internal capsule LGCST900040920.07
6508AFP levelsGCST902786150.07
6509DKK1/VEGFA ratioGCST903144830.07
6510Acetone levels (UKB data field 23477)GCST902695740.07
6511FCRL5/MZB1 ratioGCST903148040.07
6512EIF3J levelsGCST902411220.07
6513PNLIP levelsGCST904702750.07
6514Concentration of very small VLDL particlesGCST905008190.07
6515Left-hemisphere default mode network to accumbens white-matter structural connectivityGCST903027730.07
6516IDP dMRI TBSS MO Pontine crossing tractGCST900039530.07
6517ILKAP levelsGCST904696080.07
6518Phosphatidylethanolamine_40:6_[M-H]1- levelsGCST900603650.07
6519Testosterone levels (UKB data field 30850)GCST904681030.07
6520X-12038 levelsGCST902436830.07
6521Alpha-hydroxyisovalerate levelsGCST901997360.07
6522Omega-3 fatty acids to total fatty acids percentageGCST905024660.07
6523TIGIT levelsGCST904708650.07
6524Bread consumption (slices per week) (UKB data field 1438)GCST901329810.07
6525CD163/SIGLEC1 ratioGCST903137390.07
6526Body mass indexGCST900187270.07
6527Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T426ECGU0004260.07
6528rfMRI connectivity (ICA100 edge 495)GCST900053480.07
6529EBAG9/FKBP5 ratioGCST903145640.07
6530Glucose | Blood biochemistryUKBB000002880.07
6531X-12063 levelsGCST902436870.07
6532PATE4 levelsGCST902424050.07
6533PDLIM7 levelsGCST904701980.07
6534STIP1 levelsGCST904707640.07
6535Acceptance of an invitation to wear a physical activity monitorGCST900127910.07
6536FGA levelsGCST904692160.07
6537GGT5 levelsGCST904693370.07
6538ASRGL1 levelsGCST904683790.07
6539Alanine levelsGCST904970860.07
6540CCL8 levelsGCST904685860.07
6541Smoking status - Never | SmokingUKBB000007800.07
6542Testosterone levelsGCST904834870.07
6543DTI TBSS L2 Superior longitudinal fasciculus LGCST903845170.07
6544aseg global volume CC-PosteriorGCST900026070.07
6545Dihomo-linoleoylcarnitine (C20:2) levelsGCST902001440.07
6546Estimated glomerular filtration rate based on creatinine and cystatin C in bottom 99% of individuals by creatinine levelsGCST905667370.07
6547Malignant melanomaGCST904681410.07
6548CDH2/CDHR2 ratioGCST903139500.07
6549MAD1L1 levelsGCST904698360.07
6550CPB1/CTRB1 ratioGCST903142080.07
6551Physical activity (Relative amplitude)GCST900614320.07
6552IDP dMRI ProbtrackX L1 atr lGCST900042480.07
6553Alzheimer's disease (MTAG)GCST904490530.07
6554FABP1 levelsGCST904691730.07
6555PPT1 levelsGCST904277180.07
6556CD79B levelsGCST904686480.07
6557SULT1A1 levelsGCST904707810.07
6558IDP dMRI TBSS L1 Posterior limb of internal capsule RGCST900040930.07
6559MIF levelsGCST900890180.07
6560Triglycerides x low social support interaction (2df test)GCST905706810.07
6561CRKL levelsGCST904688670.07
6562EIF4B levelsGCST904690940.07
6563IDP dMRI TBSS OD Cerebral peduncle LGCST900044170.07
6564Asthma with exacerbation (PheCode 495.2)GCST904760250.07
6565STAT5B levelsGCST904707590.06
6566DBI levelsGCST904689490.06
6567Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T102ECGU0001020.06
6568FXYD5 levelsGCST904692830.06
6569IDP dMRI TBSS MD Splenium of corpus callosumGCST900040310.06
6570Turnip likingGCST900948610.06
6571ESM1 levelsGCST900120680.06
6572COPDFING000003500.06
6573TMSB10/TXNRD1 ratioGCST903159250.06
6574PDGFB/SPINT2 ratioGCST903156290.06
6575SPARC/TJAP1 ratioGCST903158730.06
6576SNAP29/SNX9 ratioGCST903158590.06
6577KAZN levelsGCST904696660.06
6578HS1BP3 levelsGCST904694770.06
6579F-strong vegetable liking (derived food-liking factor)GCST900948520.06
6580QDPR/THOP1 ratioGCST903157570.06
6581CANT1/VSIR ratioGCST903136210.06
6582IDP dMRI TBSS MD Body of corpus callosumGCST900040300.06
6583CD14 levelsGCST904685980.06
6584Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T474ECGA0004740.06
6585Omega-6 fatty acid levelsGCST905020940.06
6586DTI TBSS L3 Superior corona radiata RGCST903845480.06
6587CYTL1 levelsGCST904689400.06
6588Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)FING000001430.06
6589Cholesteryl ester_18:0_[M+NH4]1+ levelsGCST900602220.06
6590PNMA1 levelsGCST904702760.06
6591ANGPT1/PDGFA ratioGCST903132660.06
6592CXCL12/TIMP3 ratioGCST903143380.06
6593CLEC4D/CLEC6A ratioGCST903141090.06
6594Other chondrocalcinosisFING000009770.06
6595TARBP2/TDRKH ratioGCST903159020.06
6596Triacylglycerol_51:3_[M+NH4]1+ levelsGCST900604940.06
6597N6-acetyllysine levels in chronic kidney diseaseGCST902575310.06
6598CDHR1 levelsGCST904686780.06
6599PSME1 levelsGCST904703600.06
6600Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T52ECGA0000520.06
6601Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T494ECGU0004940.06
6602PDGFA/VEGFC ratioGCST903156220.06
6603MAP4K5 levelsGCST904698550.06
6604IKBKG levelsGCST904695420.06
6605GKN2 levelsGCST900894130.06
6606Handedness (chirality/laterality) - Right-handed | Early life factorsUKBB000003030.06
6607Milk type used - Skimmed | DietUKBB000004700.06
6608SCAMP3/VPS53 ratioGCST903158070.06
6609IDP T1 FAST ROIs L cerebellum VIIbGCST900025750.06
6610PGD levelsGCST904702170.06
6611Phosphatidylcholine_32:0_[M+H]1+/Phosphatidylethanolamine_35:0_[M+H]1+/Phosphatidate_37:1_[M+NH4]1+ levelsGCST900602700.06
6612TJAP1 levelsGCST904708740.06
6613Sjögren's syndromeGCST900187000.06
6614NTRK3/SCARF2 ratioGCST903155710.06
6615IDP T1 FAST ROIs R hippocampusGCST900025560.06
6616Open wounds of extremities (PheCode 871)GCST904762850.06
6617EDAR/TACC3 ratioGCST903145890.06
6618Gestational [pregnancy-induced] hypertensionFING000005710.06
6619Linoleic acid to total fatty acids percentageGCST905023330.06
6620GFER levelsGCST904693260.06
6621DTI TBSS MO Pontine crossing tractGCST903846210.06
6622GRAP2/MAP4K5 ratioGCST903149820.06
6623DKK1/VASH1 ratioGCST903144820.06
6624Other noninfective gastroenteritis and colitisFING000010770.06
6625DTI TBSS L3 Posterior corona radiata RGCST903845500.06
6626NSFL1C/PSMG3 ratioGCST903155590.06
6627APOB/APOA1 ratioGCST902695380.06
6628LMNB2 levelsGCST904697820.06
6629CASP8/RILP ratioGCST903136570.06
6630Diastolic blood pressure x sex interactionGCST903351750.06
6631ICD10 C50.9: Malignant neoplasm of breast of unspecified siteGCST900438890.06
6632aparc-pial rh area lateralorbitofrontalGCST900031850.06
6633Illnesses of siblings - Heart disease | Family historyUKBB000003510.06
6634aparc-a2009s rh area S-oc-middle+LunatusGCST900034270.06
6635RND3 levelsGCST904222300.06
6636TFPI2 levelsGCST904708380.06
6637Bitter ale likingGCST900947050.06
6638CXCL5/PLXNA4 ratioGCST903143510.06
6639aseg lh intensity Cerebellum-CortexGCST900037670.06
6640Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T94ECGU0000940.06
6641FKBP4 levelsGCST904692430.06
6642FABP9 levelsGCST904691790.06
6643LGALS8/TXNDC5 ratioGCST903153210.06
6644DTI autoptx L3 slf r tractGCST903852150.06
6645ART3/RGMB ratioGCST903133630.06
6646Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T442ECGU0004420.06
6647TNFSF14 levelsGCST902748420.06
6648TPMT levelsGCST904709450.06
6649F-healthy food liking (derived food-liking factor)GCST900947790.06
6650EDAR/TNFSF12 ratioGCST903145910.06
6651Volume of right lateral nucleusGCST904749220.06
6652CNPY4/STAT5B ratioGCST903141550.06
6653Milk chocolate likingGCST900948010.06
6654NDUFB7 levelsGCST904700150.06
6655N-acetylglycine levelsGCST902435610.06
6656Cholesterol to total lipids ratio in chylomicrons and extremely large VLDLGCST900930410.06
6657RND3 levelsGCST906180660.06
6658VEGFA levelsGCST904710340.06
6659CCL17/PDGFB ratioGCST903136880.06
6660PLIN3/VSIR ratioGCST903156790.06
6661ITGB1/NCAM1 ratioGCST903152270.06
6662Shortness of breath (PheCode 512.7)GCST904760400.06
6663Omega-3 fatty acids to total fatty acids percentageGCST905024630.06
6664creatinine (maximum, inv-norm transformed)GCST904752260.06
6665Total testosterone levelsGCST900121120.06
6666Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T78ECGU0000780.06
6667Left eye overall retinal pigment epithelium thicknessGCST906720320.06
6668ANXA4/HSPB1 ratioGCST903132920.06
6669Bone marrow fat fraction of lumbar vertebra 4GCST906523890.06
6670FKBP4/FKBP5 ratioGCST903148380.06
6671Sleep disorders | neurologicalUKBB000007760.06
6672HYOU1 levelsGCST904694960.06
6673SELP/VSIR ratioGCST903158220.06
6674LSIL lesion of the cervix uteri, vagina or vulvaFING000007330.06
6675Lactose intolerance, other/unspecifiedFING000007120.06
6676Hot drink temperature | DietUKBB000003290.06
6677IGSF8/VSIR ratioGCST903151410.06
6678Frailty (Factor 4 - Metabolic Problems)GCST906240500.06
6679CA6/DNER ratioGCST903135940.06
6680Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T471ECGU0004710.06
6681Average diameter for HDL particles (UKB data field 23433)GCST902695300.06
6682CD40LG/EDAR ratioGCST903138180.06
6683Effects radiation NOS (PheCode 990)GCST904762930.05
6684DTI TBSS L3 FornixGCST903845290.05
6685Parkinson's disease or first degree relation to individual with Parkinson's diseaseGCST0093250.05
6686Volume of left whole amygdalaGCST904749860.05
6687Type 2 diabetesGCST900860710.05
6688Degeneration of intervertebral disc (PheCode 722.6)GCST904762380.05
6689AXL/GAS6 ratioGCST903134190.05
6690aparc-Desikan rh volume postcentralGCST900028220.05
6691Breast cancerGCST0072360.05
6692aseg rh intensity Cerebellum-CortexGCST900037810.05
6693MTIF3 levelsGCST904699570.05
6694Alkenylphosphatidylcholine (P-16:0/16:0) levelsGCST900255630.05
6695HEXIM1/IPCEF1 ratioGCST903150460.05
6696Seborrhoeic keratosisFING000012830.05
6697Basal cell carcinoma, excluding all cancers (controls excluding all cancers)FING000001420.05
6698SPINK4 levelsGCST904707230.05
6699Principal component-derived dietary pattern 46GCST901330510.05
6700PCBD1 levelsGCST904701660.05
6701Histidine levelsGCST900928300.05
6702Height decline (difference score)GCST905658630.05
6703Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T459ECGU0004590.05
6704NADK levelsGCST904699930.05
6705Dissociative [conversion] disordersFING000004680.05
6706rfMRI amplitudes (ICA100 node 2)GCST900045900.05
6707IL1R1 levelsGCST904695710.05
6708ADAM23 levelsGCST904682190.05
6709Glycoprotein acetyls levelsGCST904973280.05
6710CCL17/CD69 ratioGCST903136840.05
6711IDP dMRI TBSS L1 Superior longitudinal fasciculus LGCST900041160.05
6712HayfeverGCST904681310.05
6713Lysophosphatidylcholine (26:0) [sn2] levelsGCST900254280.05
6714DBNL/HEXIM1 ratioGCST903144170.05
6715PAM levelsGCST904701560.05
6716Non-ischemic cardiomyopathyFING000008730.05
6717rfMRI connectivity (ICA100 edge 995)GCST900058480.05
6718Other diseases of blood and blood-forming organsFING000009980.05
6719CLEC7A levelsGCST904687780.05
6720ADAMTS4 levelsGCST904682260.05
6721Urinary albumin-to-creatinine ratioGCST0096400.05
6722Histidine levels (UKB data field 23463)GCST902695600.05
6723CD244/CD84 ratioGCST903137620.05
6724Mean carotid IMT (intima-medial thickness) at 240 degrees | Carotid ultrasoundUKBB000004460.05
6725Cholesteryl ester levels in large HDLGCST900928460.05
6726aparc-Desikan rh volume fusiformGCST900028070.05
6727HMOX2/TDRKH ratioGCST903150670.05
6728Gestational diabetes (for exclusion)FING000005730.05
6729C1QTNF1 levelsGCST904684880.05
6730IDP dMRI TBSS OD Pontine crossing tractGCST900044030.05
6731White blood cell countGCST900259850.05
6732In your lifetime, have you smoked a total of at least 100 cigarettes?GCST904763870.05
6733Disorders of breastFING000004370.05
6734Cystatin C levels in bottom 99% of individuals by creatinine levelsGCST905667340.05
6735Social trust (aggregated)GCST903193150.05
6736GMFG levelsGCST904693660.05
6737Lymphocyte countGCST900023170.05
6738AmygNuclei rh volume Central-nucleusGCST900026620.05
6739ARHGEF1 levelsGCST904683590.05
6740Androstenediol (3alpha, 17alpha) monosulfate (3) levelsGCST901998560.05
6741LTB4R levelsGCST904221640.05
6742DHX58 levelsGCST906182380.05
6743OMD/SPP1 ratioGCST903155860.05
6744SERPINH1 levelsGCST904706010.05
6745Butyrylcarnitine levelsGCST902435890.05
6746Unspecified dementiaFING000014000.05
6747BACH1/SNX9 ratioGCST903134470.05
6748Ulcerative rectosigmoiditisFING000013940.05
6749DUT levelsGCST904690540.05
6750Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T89ECGU0000890.05
6751Retinal thickness (functional principal component 4)GCST904557240.05
6752LYN/YES1 ratioGCST903153510.05
6753Acetone levelsGCST900928050.05
6754FLT3LG levelsGCST904692500.05
6755IL7 levelsGCST904696060.05
6756NUB1 levelsGCST904700990.05
6757SARG levelsGCST904705260.05
6758DBI/TMSB10 ratioGCST903144140.05
6759PEAR1/SNAP23 ratioGCST903156430.05
6760Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T433ECGU0004330.05
6761aparc-pial lh area supramarginalGCST900031710.05
6762DNAJA2/FIS1 ratioGCST903145010.05
6763Inflammatory markers and poor diet (confirmatory factor analysis Factor 30)GCST903093640.05
6764Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T458ECGU0004580.05
6765Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T476ECGU0004760.05
6766F-savour/caloric food liking (derived food-liking factor)GCST900948350.05
6767ADGRE5/ITGB2 ratioGCST903131800.05
6768Takes medication for acid reflux/GERD?GCST904753210.05
6769Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T468ECGA0004680.05
6770Insomnia (weighted GWA)GCST902672870.05
6771Sleep apnea (MTAG)GCST902673620.05
67723-hydroxybutyrate levels (UKB data field 23474)GCST902695710.05
6773Glucose levelsGCST901327240.05
6774Methods of admission to hospital (recoded) - Emergency admission: A&E | Summary AdministrationUKBB000004640.05
6775IDP dMRI TBSS MO Cerebral peduncle LGCST900039670.05
6776Principal component-derived dietary pattern 3GCST901330080.05
6777PEAR1 levelsGCST904702040.05
6778ERBB4/F3 ratioGCST903146900.05
6779EFNA4/LAYN ratioGCST903146020.05
6780Omega-3 fatty acids to Omega-6 fatty acids ratioGCST905024110.05
6781Urine glycine conjugate of C10H14O2 (1)* levels in chronic kidney diseaseGCST902652740.05
6782SLC39A14 levelsGCST904706600.05
6783T1 FreeSurfer DKT rh supramarginal volumeGCST903843770.05
6784NPHS2 levelsGCST904700710.05
6785CA9/CBLIF ratioGCST903135950.05
6786Leucine levels (UKB data field 23466)GCST902695630.05
6787KIF22 levelsGCST904696820.05
6788wg lh intensity-contrast rostralmiddlefrontalGCST900038180.05
6789Alkenylphosphatidylethanolamine (P-20:0/18:2) levelsGCST900250560.05
6790Fracture of shoulder and upper armFING000005590.05
6791DRG2 levelsGCST904690390.05
6792Platelet countGCST902786400.05
6793DTI autoptx FA slf r tractGCST903851340.05
6794LEPR/NRCAM ratioGCST903153120.05
6795DTI TBSS FA Sagittal stratum LGCST903844110.05
6796CD58/SIRPB1 ratioGCST903138550.05
6797Phospholipids to total lipids in medium HDL percentage (UKB data field 23639)GCST902697360.05
6798LY6D/NECTIN4 ratioGCST903153440.05
6799Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T80ECGA0000800.05
6800ANXA1 levelsGCST902402960.05
6801Cholesterol to total lipids ratio in very large HDLGCST900930050.05
6802Left-hemisphere visual network to right-hemisphere salience/ventral attention network white-matter structural connectivityGCST903026580.05
6803ITGB6 levelsGCST904696460.05
6804IGF2R/LGMN ratioGCST903151310.05
6805EIF4E levelsGCST904690960.05
6806rfMRI amplitudes (ICA100 node 7)GCST900045950.05
6807MIF/PARK7 ratioGCST903154470.05
6808AXL/VCAM1 ratioGCST903134230.05
6809MESD/SNX9 ratioGCST903154230.05
6810GLRX5 levelsGCST904693610.05
6811Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T75ECGU0000750.05
6812Phospholipids to total lipids in very small VLDL percentage (UKB data field 23604)GCST902697010.05
6813Wheeze or whistling in the chest in last year | BreathingUKBB000009120.05
6814Facial ageing | Sun exposureUKBB000002330.05
6815rfMRI connectivity ICA-features 1GCST900063390.05
6816IGSF9 levelsGCST904695410.05
6817KLK8/LY6D ratioGCST903152570.05
6818PDCD6 levelsGCST904701830.05
6819T1 FreeSurfer BA lh V2 exvivo thicknessGCST903855290.05
6820FAM3B/FGF19 ratioGCST903147760.05
6821Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T463ECGA0004630.05
6822P4HB/PPP1R12A ratioGCST903155910.05
6823HSIL lesion of the vulvaFING000006260.05
6824DTYMK levelsGCST904690490.05
6825IDP dMRI TBSS OD Posterior limb of internal capsule LGCST900044210.05
6826TREH levelsGCST904709590.05
6827Diacylglycerol_36:4_[M+H-H2O]1+ levelsGCST900601880.05
6828NFASC levelsGCST904700310.05
6829TBCC/WWP2 ratioGCST903159110.05
6830wg lh intensity-contrast postcentralGCST900038130.05
6831Gamma glutamyl transferase levelsGCST902786300.05
6832LIPF levelsGCST904697800.05
6833PDGFB/ST6GAL1 ratioGCST903156300.05
6834Liver fatGCST900290730.05
6835SPRR3 levelsGCST904707370.05
6836CD69/CLEC1B ratioGCST903138690.05
6837PPIF levelsGCST904702930.04
6838CD84/TREML2 ratioGCST903139190.04
6839IRF2 levelsGCST902415660.04
6840Principal component-derived dietary pattern 32GCST901330370.04
6841IL6ST/LEPR ratioGCST903151650.04
6842Liver enzyme levels (alanine transaminase)GCST900134050.04
6843Plasma pregnenetriol sulfate* levels in chronic kidney diseaseGCST902658660.04
6844NRP1 levelsGCST904700850.04
6845FIS1 levelsGCST904692400.04
6846Neutrophil countGCST900023510.04
6847Conductive hearing loss (PheCode 389.2)GCST904759120.04
6848DTI TBSS L3 External capsule RGCST903845560.04
6849IDP dMRI TBSS L1 Retrolenticular part of internal capsule LGCST900040960.04
6850Other diseases of blood and blood-forming organs, wideFING000009990.04
6851F2R/PDGFB ratioGCST903147330.04
6852Respiratory disease (confirmatory factor analysis Factor 11)GCST903093450.04
6853Cholesterol levels in large HDLGCST900928440.04
6854Benign neoplasm of other and unspecified endocrine glandsFING000001590.04
6855Chronic lung diseases including COPD, Emphysema and BronchitisGCST904752720.04
6856Fasting plasma glucoseGCST905664200.04
6857FKBP5/MAP4K5 ratioGCST903148430.04
6858IDP dMRI ProbtrackX L1 atr rGCST900042490.04
6859DTI TBSS MD Posterior corona radiata LGCST903845990.04
6860Frequency of friend/family visits | Social supportUKBB000002620.04
6861Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T486ECGU0004860.04
6862CTSO levelsGCST904689150.04
6863Acylcarnitine (18:2) levelsGCST900246230.04
6864Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T13ECGA0000130.04
6865PMVK/PRTFDC1 ratioGCST903156950.04
6866aparc-DKTatlas rh volume postcentralGCST900029130.04
6867DTI TBSS MD Posterior thalamic radiation LGCST903846010.04
6868Phosphatidylcholine-O_40:5_[M+H]1+/Phosphatidylcholine-P_40:4_[M+H]1+ levelsGCST900604230.04
6869Neutrophil countGCST900259770.04
6870PPP1R12A/VEGFC ratioGCST903157150.04
6871TNFRSF21 levelsGCST904709120.04
6872EGLN1/PIK3AP1 ratioGCST903146190.04
6873IDP dMRI TBSS MD Posterior limb of internal capsule LGCST900040460.04
6874Disorders of plasma-protein metabolism, not elsewhere classifiedFING000004550.04
6875Cardiorespiratory fitness slopeGCST900933190.04
6876IDP dMRI ProbtrackX FA cgc rGCST900039300.04
6877Triacylglycerol_52:2_[M+NH4]1+ levelsGCST900605110.04
6878T1 FreeSurfer a2009s rh S temporal sup areaGCST903849620.04
6879HSPG2/PTGDS ratioGCST903150920.04
6880Urine 16a-hydroxy DHEA 3-sulfate levels in chronic kidney diseaseGCST902643290.04
6881Length of time at current address | HouseholdUKBB000004040.04
6882KDR levelsGCST902433230.04
6883Cauliflower likingGCST900947270.04
6884Phospholipids in medium HDLGCST904986350.04
6885Glucose levels (UKB data field 30740)GCST904680710.04
6886Congestive heart failure (CHF) NOS (PheCode 428.1)GCST904759820.04
6887SRC levelsGCST904707410.04
6888Myocardial fractal dimension (slice 6)GCST900002920.04
6889DIABLO/PDGFB ratioGCST903144680.04
6890AK2 levelsGCST904682700.04
6891DTI TBSS L3 Anterior limb of internal capsule LGCST903845410.04
6892CD63/CLEC1B ratioGCST903138630.04
6893rfMRI connectivity (ICA100 edge 387)GCST900052400.04
6894CELA3A/CTRC ratioGCST903140120.04
6895Testosterone levelsGCST904834860.04
6896Defects in the complement systemFING000003830.04
6897CCN2/MGLL ratioGCST903137140.04
6898Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T91ECGU0000910.04
6899DXO levelsGCST904690550.04
6900Cholesteryl esters in medium HDL (UKB data field 23569)GCST902696660.04
6901CLEC1B/TXNDC5 ratioGCST903141050.04
6902Plasma 3-hydroxyhexanoate levels in chronic kidney diseaseGCST902644980.04
6903F-fatty food liking (derived food-liking factor)GCST900947610.04
6904DTI autoptx FA ilf r tractGCST903851270.04
6905LACTB2 levelsGCST904697260.04
6906AXIN1/CLIP2 ratioGCST903134040.04
6907USP8 levelsGCST904710220.04
6908Phosphatidylcholine-O_33:3_[M+H]1+/Phosphatidylcholine-P_33:2_[M+H]1+/Phosphatidylethanolamine-O_36:3_[M+H]1+ levelsGCST900602610.04
6909RAB2B levelsGCST904704060.04
6910FABP5/PPCDC ratioGCST903147630.04
6911DTI TBSS L2 Anterior corona radiata RGCST903844980.04
6912NUDT2 levelsGCST904701060.04
6913MAVS/MYO9B ratioGCST903153900.04
6914Neuroendocrine tumor and carcinoma of stomach, excluding all cancers (controls excluding all cancers)FING000008660.04
6915wg lh intensity-contrast lateraloccipitalGCST900038020.04
6916CX3CL1/PODXL2 ratioGCST903143260.04
6917Right-hemisphere dorsal attention network to amygdala white-matter structural connectivityGCST903028110.04
6918Pizza likingGCST900948100.04
6919GP6/TMSB10 ratioGCST903149750.04
6920Phosphatidylcholine-O_32:1_[M+H]1+/Phosphatidylcholine-P_32:0_[M+H]1+/Phosphatidylethanolamine-O_35:1_[M+H]1+ levelsGCST900602540.04
6921Psoriasis vulgarisGCST900186870.04
6922SLC9A3R1 levelsGCST904706650.04
6923TPP1 levelsGCST904709460.04
6924Chronic ulcer of skin, not elsewhere classifiedFING000003000.04
6925BIN2/FYB1 ratioGCST903135050.04
6926Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T431ECGU0004310.04
6927MAP2K6/TBL1X ratioGCST903153780.04
6928PDGFA/PRSS27 ratioGCST903156160.04
6929TOR1AIP1 levelsGCST904709350.04
6930CD19 on IgD- CD38- B cellGCST900017330.04
6931FYB1/PPP1R12A ratioGCST903149130.04
6932Whole body fat mass | Impedance measuresUKBB000009140.04
6933ExotropiaGCST905727370.04
6934F-small fish liking (derived food-liking factor)GCST900948400.04
6935Total fatty acid levelsGCST905022110.04
6936RHOC/TBCC ratioGCST903157750.04
6937Biological Mother: Coronary Artery / Coronary Heart DiseaseGCST904754880.04
6938Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T475ECGU0004750.04
6939T1 CAT volume R TemporalFusiformCortexposteriordivisionGCST903840750.04
6940Omega-3 fatty acids to total fatty acids percentageGCST905020880.04
6941OCLN levelsGCST904701140.04
6942Acetate levelsGCST900928030.04
6943RCC1 levelsGCST904704430.04
6944Baked/steamed fish likingGCST900946960.04
6945Polyunsaturated fatty acid levelsGCST905021330.04
6946DTI TBSS L3 Superior fronto-occipital fasciculus RGCST903845660.04
6947T1 FreeSurfer DK rh cuneus volumeGCST903857610.04
6948IDP T1 FAST ROIs R cerebellum crus IGCST900025710.04
6949SPESP1 levelsGCST904707200.04
6950CDKN1A/TBL1X ratioGCST903139770.04
6951Cholesterol in large HDL (UKB data field 23561)GCST902696580.04
6952End-diastolic bi-ventricular shape (principal component 2)GCST904484810.04
6953IDP dMRI TBSS L1 Uncinate fasciculus LGCST900041200.04
6954IDP T1 FIRST left caudate volumeGCST900024380.04
6955Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T436ECGU0004360.04
6956GGACT levelsGCST904693330.04
6957CD8A levelsGCST904686550.04
6958Colon polypGCST900186070.04
6959Chronic lymphocytic leukemiaGCST906247380.04
6960Omega-3 fatty acids to Omega-6 fatty acids ratioGCST905023980.04
6961Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T487ECGU0004870.04
6962Dried fruit intake | DietUKBB000001930.04
6963CDH17/PECAM1 ratioGCST903139420.04
6964Cholesteryl esters in large HDL (UKB data field 23562)GCST902696590.04
6965CHGB levelsGCST904687420.04
6966Alzheimer's disease (MTAG)GCST904490620.04
6967Rheumatoid arthritis | musculoskeletalUKBB000007570.04
6968CLPP/DECR1 ratioGCST903141370.04
6969Operation code - caesarean section / caesarian section | OperationsUKBB000005520.04
6970aparc-a2009s lh volume G-postcentralGCST900029520.04
6971BCAM levelsGCST904684250.04
6972Abnormal findings examination of lungs (PheCode 514)GCST904760430.04
6973Concentration of very large HDL particles (UKB data field 23551)GCST902696480.04
6974TRAF3 levelsGCST904709570.04
6975Gout and other crystal arthrop (PheCode 274)GCST904757310.04
6976Homeostasis model assessment of beta-cell functionGCST0051800.04
6977CLPS/CTRB1 ratioGCST903141390.04
6978DTI autoptx MD str r tractGCST903852440.04
6979SnoringGCST0097600.04
6980MAP3K5 levelsGCST904698540.04
6981Waist circumferenceGCST901037530.04
6982Biological Father: High blood pressureGCST904752430.04
6983aseg lh volume Accumbens-areaGCST900026260.04
6984IDP dMRI ProbtrackX L1 slf lGCST900042670.04
6985F-glutamate liking (derived food-liking factor)GCST900947720.04
6986MPO levelsGCST900120310.04
6987Fluid intelligence score decline (log-difference score)GCST905658520.04
6988Docosahexaenoic acid to total fatty acids percentageGCST905022690.04
6989VitiligoFING000014430.04
6990LCN2/RETN ratioGCST903153080.04
6991IL15 levelsGCST904695560.04
6992Left ventricular end systole anterospetal wall thicknessGCST902785130.04
6993Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T435ECGU0004350.04
6994rfMRI connectivity (ICA100 edge 1066)GCST900059190.04
6995STK11 levelsGCST904707650.04
6996F13B levelsGCST904691670.04
6997CXADR levelsGCST904689220.04
6998Renal failureFING000012500.04
6999Main speciality of consultant (recoded) - Trauma and orthopaedics | Summary AdministrationUKBB000004200.04
7000Cholesteryl ester_18:1_[M+NH4]1+ levelsGCST900602210.04